⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DBVT News
DBV Technologies S.A.
DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document
globenewswire.com
DBVT
DBV Technologies Reports Full Year 2025 Financial Results and Business Update
globenewswire.com
DBVT
DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review
globenewswire.com
DBVT
DBV Technologies to Participate in Upcoming March Investor Conferences
globenewswire.com
DBVT
Form 8-K
sec.gov
DBVTF
DBVT
DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting
globenewswire.com
DBVT
Allergy Immunotherapy Market to Reach $4.9 billion by 2033 Globally, at 10.4% CAGR: Allied Market Research
prnewswire.com
DBVT
DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting
globenewswire.com
DBVT
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
globenewswire.com
DBVT
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
globenewswire.com
DBVT